Skip to main content
. 2020 Aug 27;131:104614. doi: 10.1016/j.jcv.2020.104614

Table 4.

Dilution series of positive patient sample pool.

Xpert® Ct N2/E Novodiag® orf1ab/N
1:1000 Posit 27.6/25.4 Posit posit/posit
Posit 27.3/24.9 Posit posit/posit
Posit 27.3/25.2 Posit posit/posit
1:10000 Posit 30.3/28.1 Posit posit/negat
Posit 30.1/28.1 Posit posit/posit
Posit 31/28.6 Negat negat/negat
1:100000 Posit 32.9/30.5 Posit negat/posit
Posit 35.1/32.1 Negat negat/negat
Posit 34.7/31.8 Negat negat/negat
1:1000000 Posit 38.4/35.3 Negat negat/negat
Posit 39.7/35.8 Negat negat/negat
1:10000000 Posit 41.4/0 N. D. N. D.
Posit 42.8/0 N. D. N. D.
1:100000000 Negat 0/0 N. D. N. D.

Ct N2/E, Ct values of N2 and E gene targets by Xpert®. orf1ab/N, result of Novodiag® system gene targets orf1ab and N. N.D., not done.